Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

Autism Spectrum Disorders: Potential Neuro-Psychopharmacotherapeutic Plant-Based Drugs.

Urdaneta KE, Castillo MA, Montiel N, Semprún-Hernández N, Antonucci N, Siniscalco D.

Assay Drug Dev Technol. 2018 Nov 14. doi: 10.1089/adt.2018.848. [Epub ahead of print]

PMID:
30427697
2.

Stem cell therapy in autism: recent insights.

Siniscalco D, Kannan S, Semprún-Hernández N, Eshraghi AA, Brigida AL, Antonucci N.

Stem Cells Cloning. 2018 Oct 23;11:55-67. doi: 10.2147/SCCAA.S155410. eCollection 2018. Review.

3.

Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders.

Siniscalco D, Schultz S, Brigida AL, Antonucci N.

Pharmaceuticals (Basel). 2018 Jun 4;11(2). pii: E56. doi: 10.3390/ph11020056. Review.

4.

Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017).

Huang H, Young W, Chen L, Feng S, Zoubi ZMA, Sharma HS, Saberi H, Moviglia GA, He X, Muresanu DF, Sharma A, Otom A, Andrews RJ, Al-Zoubi A, Bryukhovetskiy AS, Chernykh ER, Domańska-Janik K, Jafar E, Johnson WE, Li Y, Li D, Luan Z, Mao G, Shetty AK, Siniscalco D, Skaper S, Sun T, Wang Y, Wiklund L, Xue Q, You SW, Zheng Z, Dimitrijevic MR, Masri WSE, Sanberg PR, Xu Q, Luan G, Chopp M, Cho KS, Zhou XF, Wu P, Liu K, Mobasheri H, Ohtori S, Tanaka H, Han F, Feng Y, Zhang S, Lu Y, Zhang Z, Rao Y, Tang Z, Xi H, Wu L, Shen S, Xue M, Xiang G, Guo X, Yang X, Hao Y, Hu Y, Li J, Ao Q, Wang B, Zhang Z, Lu M, Li T.

Cell Transplant. 2018 Feb;27(2):310-324. doi: 10.1177/0963689717746999.

5.

Intraperitoneal Administration of Oxygen/Ozone to Rats Reduces the Pancreatic Damage Induced by Streptozotocin.

Siniscalco D, Trotta MC, Brigida AL, Maisto R, Luongo M, Ferraraccio F, D'Amico M, Di Filippo C.

Biology (Basel). 2018 Jan 11;7(1). pii: E10. doi: 10.3390/biology7010010.

6.

Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations.

Brigida AL, Schultz S, Cascone M, Antonucci N, Siniscalco D.

Int J Mol Sci. 2017 Jul 3;18(7). pii: E1425. doi: 10.3390/ijms18071425. Review.

7.

Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders.

Caprnda M, Kubatka P, Gazdikova K, Gasparova I, Valentova V, Stollarova N, La Rocca G, Kobyliak N, Dragasek J, Mozos I, Prosecky R, Siniscalco D, Büsselberg D, Rodrigo L, Kruzliak P.

Biomed Pharmacother. 2017 Jul;91:60-69. doi: 10.1016/j.biopha.2017.04.034. Epub 2017 May 23. Review.

PMID:
28448871
8.

Induced pluripotent stem cells as a cellular model for studying Down Syndrome.

Brigida AL, Siniscalco D.

J Stem Cells Regen Med. 2016 Nov 29;12(2):54-60. eCollection 2016. Review.

9.

Peripheral Inflammatory Markers Contributing to Comorbidities in Autism.

Inga Jácome MC, Morales Chacòn LM, Vera Cuesta H, Maragoto Rizo C, Whilby Santiesteban M, Ramos Hernandez L, Noris García E, González Fraguela ME, Fernandez Verdecia CI, Vegas Hurtado Y, Siniscalco D, Gonçalves CA, Robinson-Agramonte ML.

Behav Sci (Basel). 2016 Dec 14;6(4). pii: E29.

10.

Intestinal Dysbiosis and Yeast Isolation in Stool of Subjects with Autism Spectrum Disorders.

Iovene MR, Bombace F, Maresca R, Sapone A, Iardino P, Picardi A, Marotta R, Schiraldi C, Siniscalco D, Serra N, de Magistris L, Bravaccio C.

Mycopathologia. 2017 Apr;182(3-4):349-363. doi: 10.1007/s11046-016-0068-6. Epub 2016 Sep 21.

PMID:
27655151
11.

Decreased Numbers of CD57+CD3- Cells Identify Potential Innate Immune Differences in Patients with Autism Spectrum Disorder.

Siniscalco D, Mijatovic T, Bosmans E, Cirillo A, Kruzliak P, Lombardi VC, De Meirleir K, Antonucci N.

In Vivo. 2016 Mar-Apr;30(2):83-9.

PMID:
26912817
12.

Commentary: The Impact of Neuroimmune Alterations in Autism Spectrum Disorder.

Siniscalco D.

Front Psychiatry. 2015 Oct 8;6:145. doi: 10.3389/fpsyt.2015.00145. eCollection 2015. No abstract available.

13.

Beneficial Effects of Palmitoylethanolamide on Expressive Language, Cognition, and Behaviors in Autism: A Report of Two Cases.

Antonucci N, Cirillo A, Siniscalco D.

Case Rep Psychiatry. 2015;2015:325061. doi: 10.1155/2015/325061. Epub 2015 Sep 29.

14.

Mesenchymal stem cells in the treatment of type 1 diabetes mellitus.

Katuchova J, Harvanova D, Spakova T, Kalanin R, Farkas D, Durny P, Rosocha J, Radonak J, Petrovic D, Siniscalco D, Qi M, Novak M, Kruzliak P.

Endocr Pathol. 2015 May;26(2):95-103. doi: 10.1007/s12022-015-9362-y. Review.

PMID:
25762503
15.

Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study.

Bradstreet JJ, Sych N, Antonucci N, Klunnik M, Ivankova O, Matyashchuk I, Demchuk M, Siniscalco D.

Cell Transplant. 2014;23 Suppl 1:S105-12. doi: 10.3727/096368914X684916. Epub 2014 Oct 9.

PMID:
25302490
16.

Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels.

Rossi F, Perrotta S, Bellini G, Luongo L, Tortora C, Siniscalco D, Francese M, Torella M, Nobili B, Di Marzo V, Maione S.

Haematologica. 2014 Dec;99(12):1876-84. doi: 10.3324/haematol.2014.104463. Epub 2014 Sep 12.

17.
18.

Mesenchymal stem cells in treating autism: Novel insights.

Siniscalco D, Bradstreet JJ, Sych N, Antonucci N.

World J Stem Cells. 2014 Apr 26;6(2):173-8. doi: 10.4252/wjsc.v6.i2.173. Review.

19.

The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages.

Siniscalco D, Bradstreet JJ, Cirillo A, Antonucci N.

J Neuroinflammation. 2014 Apr 17;11:78. doi: 10.1186/1742-2094-11-78.

20.

Perspectives on the use of stem cells for autism treatment.

Siniscalco D, Bradstreet JJ, Sych N, Antonucci N.

Stem Cells Int. 2013;2013:262438. doi: 10.1155/2013/262438. Epub 2013 Oct 10. Review.

Supplemental Content

Loading ...
Support Center